The caroticocavernous fistula is a specific type of dural arteriovenousfistula characterized by abnormal arteriovenous shunting within the cavernous sinus.
A caroticocavernous fistula results in high-pressure arterial blood entering the low-pressure venous cavernous sinus.
This interferes with normal venous drainage patterns and compromises blood flow within the cavernous sinus and the orbit.
The caroticocavernous fistula is a specific type of dural arteriovenousfistula characterized by abnormal arteriovenous shunting within the cavernous sinus.
A caroticocavernous fistula results in high-pressure arterial blood entering the low-pressure venous cavernous sinus.
This interferes with normal venous drainage patterns and compromises blood flow within the cavernous sinus and the orbit.
Indian Dental Academy: will be one of the most relevant and exciting training center with best faculty and flexible training programs for dental professionals who wish to advance in their dental practice,Offers certified courses in Dental implants,Orthodontics,Endodontics,Cosmetic Dentistry, Prosthetic Dentistry, Periodontics and General Dentistry.
Dr Avinash.KM is a Neurosurgeon with advanced training in Interventional vascular Neurosurgery(FINR) from Zurich, Switzerland, and FMINS-Fellowship in minimally invasive and Endoscopic Neurosurgery from Germany.
He is presently working in Columbia asia hospitals, Bangalore.
His main areas of interest are Vascular Neurosurgery, Stroke specialist, interventional neuroradiology, Endovascular Neurosurgery, Endoscopic and minimally invasive Neurosurgery, Endoscopic spine surgery.He has advanced training in both Brain Aneurysm coiling and clipping, Brain AVM embolizations and its surgical removal, carotid artery stenting and carotid endarterectomy. Since he is trained both in open microvascular Neurosurgery and in Interventional Neurosurgery he helps patients in choosing the right treatment options for brain vascular diseases with out any bias of one treatment over the other.
Cranial Anastomoses and Dangerous Vascular Connections. Important for Neuroradiologists and Neurointerventionalists. You should know before embolization.
Embryology of the cranial circulation. Important to understand the anatomy of the cerebral circulation. Important for Neuroradiologists and Neurointerventionalists.
Cerebral Venous anatomy from the neuroradiology point of view. Anatomy of the cerebral veins and venous sinuses. Important for Neuroradiologists and Neurointerventionalists.
Anatomy of the posterior cerebral circulation from the neuroradiology point of view. Anatomy of the vertebral artery. Anatomy of the basilar artery. Important for Neuroradiologists and Neurointerventionalists.
Knee anatomy and clinical tests 2024.pdfvimalpl1234
This includes all relevant anatomy and clinical tests compiled from standard textbooks, Campbell,netter etc..It is comprehensive and best suited for orthopaedicians and orthopaedic residents.
NVBDCP.pptx Nation vector borne disease control programSapna Thakur
NVBDCP was launched in 2003-2004 . Vector-Borne Disease: Disease that results from an infection transmitted to humans and other animals by blood-feeding arthropods, such as mosquitoes, ticks, and fleas. Examples of vector-borne diseases include Dengue fever, West Nile Virus, Lyme disease, and malaria.
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
HOT NEW PRODUCT! BIG SALES FAST SHIPPING NOW FROM CHINA!! EU KU DB BK substit...GL Anaacs
Contact us if you are interested:
Email / Skype : kefaya1771@gmail.com
Threema: PXHY5PDH
New BATCH Ku !!! MUCH IN DEMAND FAST SALE EVERY BATCH HAPPY GOOD EFFECT BIG BATCH !
Contact me on Threema or skype to start big business!!
Hot-sale products:
NEW HOT EUTYLONE WHITE CRYSTAL!!
5cl-adba precursor (semi finished )
5cl-adba raw materials
ADBB precursor (semi finished )
ADBB raw materials
APVP powder
5fadb/4f-adb
Jwh018 / Jwh210
Eutylone crystal
Protonitazene (hydrochloride) CAS: 119276-01-6
Flubrotizolam CAS: 57801-95-3
Metonitazene CAS: 14680-51-4
Payment terms: Western Union,MoneyGram,Bitcoin or USDT.
Deliver Time: Usually 7-15days
Shipping method: FedEx, TNT, DHL,UPS etc.Our deliveries are 100% safe, fast, reliable and discreet.
Samples will be sent for your evaluation!If you are interested in, please contact me, let's talk details.
We specializes in exporting high quality Research chemical, medical intermediate, Pharmaceutical chemicals and so on. Products are exported to USA, Canada, France, Korea, Japan,Russia, Southeast Asia and other countries.
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Explore natural remedies for syphilis treatment in Singapore. Discover alternative therapies, herbal remedies, and lifestyle changes that may complement conventional treatments. Learn about holistic approaches to managing syphilis symptoms and supporting overall health.
Flu Vaccine Alert in Bangalore Karnatakaaddon Scans
As flu season approaches, health officials in Bangalore, Karnataka, are urging residents to get their flu vaccinations. The seasonal flu, while common, can lead to severe health complications, particularly for vulnerable populations such as young children, the elderly, and those with underlying health conditions.
Dr. Vidisha Kumari, a leading epidemiologist in Bangalore, emphasizes the importance of getting vaccinated. "The flu vaccine is our best defense against the influenza virus. It not only protects individuals but also helps prevent the spread of the virus in our communities," he says.
This year, the flu season is expected to coincide with a potential increase in other respiratory illnesses. The Karnataka Health Department has launched an awareness campaign highlighting the significance of flu vaccinations. They have set up multiple vaccination centers across Bangalore, making it convenient for residents to receive their shots.
To encourage widespread vaccination, the government is also collaborating with local schools, workplaces, and community centers to facilitate vaccination drives. Special attention is being given to ensuring that the vaccine is accessible to all, including marginalized communities who may have limited access to healthcare.
Residents are reminded that the flu vaccine is safe and effective. Common side effects are mild and may include soreness at the injection site, mild fever, or muscle aches. These side effects are generally short-lived and far less severe than the flu itself.
Healthcare providers are also stressing the importance of continuing COVID-19 precautions. Wearing masks, practicing good hand hygiene, and maintaining social distancing are still crucial, especially in crowded places.
Protect yourself and your loved ones by getting vaccinated. Together, we can help keep Bangalore healthy and safe this flu season. For more information on vaccination centers and schedules, residents can visit the Karnataka Health Department’s official website or follow their social media pages.
Stay informed, stay safe, and get your flu shot today!
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
5. a) Definition :
-A carotid cavernous fistula (CCF) consists of an
abnormal connection between the cavernous
segment of the internal carotid artery (ICA) and
the cavernous sinus
-The resulting high-flow shunt raises pressure in
the drainage pathways of the cavernous sinuses
and causes symptoms due to venous
hypertension in the orbit , cortical or deep
cerebral veins and venous stenosis due to
secondary hyperplasia
6. -It is the most frequent location of direct
intracranial arteriovenous fistulas and the
majority are caused by trauma
-Spontaneous fistulas are caused by rupture of an
aneurysm of the cavernous ICA or other arterial
diseases that weakens the wall
-The connection is usually a single hole or less
frequently a small number of individual holes
-The point of rupture in the arterial wall is often
large (1-10 mm) and spontaneous cure is
therefore rare
8. 1-Traumatic (80%) :
a) Accidental blunt trauma due to motor vehicle
accidents (MVA) with direct deceleration injury to
the face and cranium is the commonest history
followed by falling from ladders , buildings ,
horses etc.
b) Arterial injury may occur due to penetrating
injury , gunshot and other missile wounds
c) Iatrogenic trauma : Iatrogenic injuries to the ICA
can occur during trans-sphenoidal
hypophysectomy , paranasal and other types of
intracranial surgery , endovascular treatment
involving angioplasty or Fogarty catheters for
endarterectomy has in the distant past been
blamed for causing arterial injury and fistulas
9. -The passage of the ICA through the skull base
creates bends with fixed sections below the
cavernous sinus where it runs through its canal
in the petrous bone and foramen lacerum , and
above at the dural ring where it is tightly
adherent to dura
-Though held within the arachnoid reflections and
dura of the cavernous sinus , this ICA section is
less supported and particularly prone to injury
following craniofacial deceleration trauma
10. -It is also vulnerable to trauma causing fractures
(e.g. facial bones , skull base) or penetration
wounds
-The mechanism of arterial wall injury is thus either
direct traumatic penetration , tearing of the wall
or avulsion of branch arteries
-If the injured patient is comatose , the diagnosis of
CCF may be delayed because objective signs
take time to become evident or because they are
initially attributed to direct traumatic soft tissue
damage
-Furthermore , the onset of the fistula may not
necessarily occur at the time of trauma , since a
traumatic pseudoaneurysm of the ICA may be
caused which later ruptures to cause a delayed
fistula
11. 2-Spontaneous (20%) :
-The fistula is caused by breakdown in the wall of
a diseased ICA
-The arterial diseases that may be responsible are:
1-Intracavernous Aneurysm
2-Ehler’s-Danlos Syndrome
3-Pseudoxanthoma Elasticum
4-Fibromuscular Dysplasia
12. 1-Intracavernous Aneurysm :
-The presumed cause is usually atherosclerosis
because spontaneous CCF is a disease of older
women
2-Ehler’s-Danlos Syndrome :
-CCF is the most common intracranial
complication of this autosomal dominant
abnormality of collagen metabolism
-It is associated with defects in arterial media and
bleeding due to increased vessel fragility
-Affected people may develop intracranial
aneurysms , and CCFs may be due to rupture of
an intracavernous aneurysm , but when it occurs
, a section of arterial wall is affected in a series
of fistulas , consistent with a diseased (and
weaken) arterial wall
13. 3-Pseudoxanthoma Elasticum :
-Autosomal recessive and dominant forms cause
disruption of elastic fibres in skin , arteries and
eye
-It is a rare cause of G1 bleeding and CCFs
4-Fibromuscular Dysplasia :
-CCF ha also been reported in this condition but it
must be rare, and there have been no recent
similar reports so the association is dubious
14. c) Anatomy of the Cavernous Sinus :
-The cavernous sinus lies lateral to the pituitary
gland and the body of the sphenoid bone
-It extends from the superior orbital fissure to the
apex of the petrous temporal bone
-It is honeycombed by numerous fibrous strands
and traversed by the cavernous portion of the
ICA
-The lateral wall is thicker than the medial wall
(which separates it from the pituitary gland) and
is formed by a double layer of dura
15. -The oculomotor cranial nerves (IIIrd , IVth
and VIth) run within the layers of the
lateral wall
-Anteriorly it receives the superior and
inferior ophthalmic veins , cerebral (uncal)
veins and the sphenoparietal sinus
-It communicates with the opposite
cavernous sinus via a series of anterior
and posterior intercavernous sinuses
16.
17. -The normal outflow is to :
1-The superior and inferior petrosal sinuses
2-The pterygomaxillary venous plexus via
emissary veins
3-The contralateral cavernous sinus
4-And , depending on head position, to the
superior and inferior ophthalmic veins
-The VIth cranial nerve lies closest to the
ICA within the inferior portion of the sinus
18. Patient with a cavernous carotid fistula of the left side after ICA injection , on
the left side contrast is seen in orbital veins ( white arrows ) and in the
pterygoid plexus ( short arrows) , the intercavernous sinus drains to the right
cavernous sinus and then to the inferior petrosal sinus (arrowheads)
19. d) Clinical Picture :
-The commonest presentation is with visual
dysfunction and orbital congestion because the
fistula flows to the orbital veins
-Occasionally, if the superior ophthalmic vein
(SOV) is absent or thrombosed , orbital signs
may be absent or alternatively occur in the
contralateral eye when venous flow is directed
through intracavernous anastomotic connections
20. -Less often , decompression occurs :
1-Posteriorly (via the inferior petrosal sinus)
2-Laterally (via the superior petrosal sinus)
3-Inferiorly (via emissary veins of the foramen rotundum
and foramen ovale to the pterygoid plexus)
4-Superiorly (via the sphenoparietal sinus)
-It is unusual for leptomeningeal and cortical veins to be
involved but since the cavernous sinus connects to the
sphenoparietal sinus , uncal veins and the petrosal
sinuses , raised venous pressure may occur in either the
superficial or deep cerebral venous systems
22. 1-Bruit :
-An almost constant complaint in the conscious
patient is bruit , which may be heard on
auscultation
-The site at which it is loudest gives a clue to the
direction of blood flow from the cavernous sinus
-Thus if the bruit is loudest over the orbit , flow is
anterior and if loudest over the mastoid bone ,
flow is predominantly posterior
-Other causes of similar objective bruit are dural
arteriovenous fistula , absence or hypoplasia of
the sphenoid wing and transmitted sound from
carotid stenosis
23. 2-Visual Disturbance & Diplopia :
-Visual loss caused by damage to the optic nerve
at the time of trauma should be distinguished
from secondary visual disturbance due to CCF
-Permanent post-traumatic monocular blindness is
caused by irreparable damage to the IInd cranial
nerve , otherwise , visual acuity is rarely
severely affected by CCF alone
-The signs are an afferent papillary defect , mild
constriction of the visual fields and rarely central
scotoma
24. -The mechanism is probably a combination of
compression by the enlarged SOV and ischemia
due to the reduced arteriovenous gradient
-Venous hypertension within the orbital veins
causes functional changes that lead to
symptoms
-Most serious is secondary glaucoma caused by
reduced drainage of aqueous humour and a rise
in intraocular pressure (IOP)
25. -Orbital venous congestion causes :
1-Raised IOP
2-Venous retinopathy
3-Proptosis
4-Chemosis , edema of lids and dilated conjunctival
vessels
5-Ophthalmoplegia
-Unilateral fistulas may cause bilateral orbital congestion
(about 20% of cases) , localisation to the side of the
fistula is usually obvious by asymmetry of proptosis or
bruit (unless the SOV is thrombosed) , only 1% of
traumatic fistulas are bilateral
26. 3-Cranial Nerve Palsies :
-Damage to the orbital cranial nerves at the time of
trauma can be distinguished from secondary
palsies by the history and initial findings on
examination
-Early complete cranial nerve palsy has a poor
prognosis and is usually caused by direct
trauma
The cranial nerves of the cavernous sinus are
commonly affected
27. -Isolated IIIth or VIth and combined IIIth + IVth +
VIth cranial nerve palsies are common
-An isolated IVth palsy is said never to occur and
palsies of V1 and V2 are seen but less often
-Muscle weakness due to palsy of the trigeminal
motor division is never caused by CCF alone
-The mechanism of palsies affecting the cavernous
cranial nerves is thought to be due to
interference with their blood supply in the sinus
either by a steal effect or compression of their
vasa nervorum by the enlarged sinus
28. 4-Epistaxis :
-This is usually associated with traumatic CCF and
is attributed to acute vessel damage which may
or may not progress to cause a CCF
-The mechanisms are usually difficult to
demonstrate but may be rupture of a
pseudoaneurysm into the sphenoid or ethmoid
sinuses or secondary to venous hypertension
and engorgement in the pterygoid plexus
29. 5-Cerebral Dysfunction :
-Cerebral ischemia or infarction occurs if the CCF
reduces perfusion to the hemisphere
-This is seen at angiography when all contrast
injected in the ICA flows to the cavernous sinus ,
and the middle cerebral artery territory depends
on collateral blood flow
-Symptoms of cerebral ischemia or infarction occur
if the collateral support is inadequate
-Venous back pressure may affect the brain stem
due to reflux to the basal vein of Rosenthal or
petrosal veins
30. 6-Spontaneous Intracranial Hemorrhage :
-Intracerebral hemorrhage is caused by
raised venous pressure within
subarachnoid or cortical veins
-Drainage to the sphenoparietal sinus may
cause cortical venous hypertension in the
Sylvian veins and very rarely hemorrhage
when other routes are obstructed
-Partial embolisation with closure of other
drainage routes may theoretically cause or
exacerbate cortical venous hypertension
32. 1-Orbital Ultrasound :
-This may show a dilated superior orbital vein (SOV) and
disc swelling suggesting the diagnosis
2-CT & CTA :
-Is useful for demonstrating the extent of injury after trauma
-It will demonstrate fractures around the orbit , paranasal
sinuses , skull base and intra- or extra-axial hematomas
or small cerebral contusions
-Proptosis
-A dilated SOV is usually well demonstrated after contrast
enhancement , and the ipsilateral cavernous sinus may
be enlarged
-Orbital edema
33. Axial CT (a) and MRI (b) of a patient with left side proptosis due to
enlarged orbital veins and soft tissue swelling , the T2 shows an
aneurysm in the left cavernous sinus , the fistula is the result of its
rupture
34. 3-MRI & MRA :
-Findings of CCFs include a dilated CS with multiple signal intensity
void structures that are associated with proptosis and an
enlarged superior ophthalmic vein
-Is generally no better than CT but is the best modality for
follow-up imaging after treatment but MRA with high-
frequency imaging may be useful
4-Cerebral Angiography :
-Is required to evaluate the fistula prior to endovascular
treatment
-Rapid shunting from ICA to CS
-Enlarged draining veins
-Retrograde flow from CS , most commonly into the ophthalmic
veins
35. Lateral ICA DSA showing a cavernous carotid fistula draining to an
enlarged superior ophthalmic vein (white arrow) to pterygoid veins
via the inferior ophthalmic vein (single short arrows) , to the inferior
petrosal sinuses (double short arrows) and to the superior petrosal
sinuses (triple short arrows)
36. f) Treatment :
1-Aims of Treatment
2-Risks and Benefits of Balloon
Embolisation
3-Preprocedure Assessment
4-Endovascular Treatments
37. 1-Aims of Treatment :
-The aim of treatment is to occlude the connection
between ICA and the cavernous sinus
-An inflatable detachable balloon , mounted on a
flexible catheter , can be ‘floated’ through the
fistula
-Once through and in the cavernous sinus , it is
inflated to close the arterial breach from the
venous side and then detached
-This is one of the most rewarding treatments in
the whole of our repertoire because the
angiographic result is immediate ; the patient
reports relief of the bruit and signs of orbital
congestion reduce within hours
38. 2-Risks and Benefits of Balloon Embolisation :
-Cure rates of 85-95% have been reported with
immediate resolution of bruit , normalization of
intraocular pressure within 48 h and resolution of
orbital congestion in 7-10 days
-On the other hand , two major risks are
associated with balloon embolisation , these are:
a) Cerebral ischaemic symptoms or infarction
caused by obstruction to the ICA
b) Exacerbation of venous hypertension
39. -First , closure of the fistula may cause (by design
or inadvertently) ICA occlusion
-In most cases , the patient may tolerate this
because the fistula has already reduced the
effective blood supply to the brain from the ICA ,
but functional testing prior to embolisation
should be considered
-The risk to the cerebral blood supply is greater if
the treatment is performed transarterially
because of the risk of distal migration of the
balloon
40. -The second major concern is paradoxical
exacerbation of orbital congestion
because of failure to completely close the
fistula or because of induced thrombosis in
large orbital veins leads to extensive
orbital thrombophlebitis which may
endanger vision , the patient should be
warned that swelling may temporarily
worsen after ‘successful’ treatment
41. -Other risks involve damage to the artery or veins
during catheterization and delayed recurrence of
the fistula
-The latter occurs mostly in the first few days after
treatment due to incomplete closure or
premature balloon deflation
-Delayed cranial pain is associated with
enlargement of silicone balloons as a result of
osmotic pressure differences between the fluid
(i.e. saline) used to inflate them and body fluids ,
this complication has been managed by
percutaneous trans-foramen ovale or trans-
sphenoidal puncture and deflation of the balloon
42. 3-Preprocedure Assessment : DSA
-A six-vessel angiogram is recommended for
a complete understanding of the fistula
morphology
-This should be with high-frame-rate
angiography , because the hole is
obscured by rapid contrast filling of the
cavernous sinus
-Injection into the contralateral ICA or a
vertebral artery with compression of the
ipsilateral ICA is performed
43. -It is important to demonstrate the integrity of the
circle of Willis and exclude other lesions (e.g.
pseudoaneurysm or CCF of the contralateral
sinus)
-External carotid artery injections are needed to
exclude a coexisting DAVF and development of
collaterals
-When trauma has ruptured a branch of the
inferolateral trunk , the fistula may be fed by
meningeal branches of the ECA.
-3D reconstruction of the angiograms is very useful
in identifying the fistula point(s) and is now
performed as a routine method of showing the
anatomy
44. 4-Endovascular Treatments :
-Endovascular treatment has replaced surgical
trapping and is required for virtually all CCFs
since visual loss has been reported in 26% of
untreated patients due to glaucoma , retinopathy
, optic neuropathy or corneal ulceration
-Though , it is often preferable to wait 1 or 2 weeks
following trauma or onset of spontaneous
fistulas , because delaying treatment allows the
fistula (morphology and flow) to stabilize and
collateral cerebral blood flow to develop
45. -However , some fistulas have clinical and
angiographic features that require treatment in
the acute phase
-Venous hypertension , within the draining
leptomeningeal and cortical veins , is a risk
factor for cerebral hemorrhage and is a common
reason for early intervention
-Progressive loss of vision or suspected ‘steal’ of
cerebral flow by the fistula are other instances
where emergency treatment should be
considered , and once IOP is consistently
elevated , definitive treatment should be
performed within 1 week
46. a) Medical Management
b) Transarterial Embolisation
c) Transvenous Embolisation
d) Postoperative Care
e) Follow-Up
47. a) Medical Management :
-Medical treatment should be given to protect the
cornea (if proptosis is severe) and simple
measures such as sleeping with the head
elevated are suggested
-Treatments to reduce IOP include topical
adrenaline or pilocarpine (with care) especially
in patients with a family history of glaucoma and
, if ineffective , with carbonic anhydrase
inhibitors (acetazolamide or methazolamide)
48. b) Transarterial Embolisation :
-The endovascular treatment techniques are
divided into transarterial and transvenous
approaches
-The transarterial route is generally
preferred because the venous route is
usually more difficult and is associated
with higher failure rates , for these reasons
, it should be considered second choice
50. 1-Balloons :
-Detachable balloons are made of either
latex or silicone and are mounted on 2-3 F
single catheter or 2 F/4 F coaxial systems
-They are introduced via a 6-9 F guiding
catheter , depending on the size of the
balloon
-Partial inflation of the balloon allows it to be
flow-guided through the fistula
51. -However , there were several potential
difficulties when using detachable balloons
, these are :
1-Unreliable detachment control
2-Flow-dependent navigation with only
limited control in positioning
3-Unpredictable volume variations
52. -Often a single balloon is adequate to achieve
complete occlusion of the fistula
-However , where there is a large venous
compartment within the cavernous sinus ,
typically seen in chronic CCFs , more balloons
will be needed
-The more balloons needed , the less compliant
the venous side becomes , and consequently ,
the greater the risk that the last balloon will
protrude into and occlude the ICA
53. -Alternatively , if a balloon will not pass through a small
fistula , the operator has the option of using it to occlude
the ICA at the site of the arterial hole , if functional
testing has predicted that the patient will tolerate the
occlusion
-Acutely after trauma , it may be best to defer ICA occlusion
until any cerebral swelling or subarachnoid hemorrhage
has resolved
-Temporary ICA occlusion with clinical testing is obviously
best , but if angiography demonstrates (i.e. delay in
venous filling between the two hemispheres of <2 s) that
an adequate collateral blood supply to the ipsilateral
hemisphere has been established , then occlusion can
be performed
54. -An alternative technique is to use a combination
of nondetachable and detachable balloons
-The first is inflated distal to the fistula both to
protect the distal circulation from migration of a
premature detached balloon and help to direct
the detachable balloon through the fistula
-If ICA occlusion is performed , deployment of
tandem balloons to insure against deflation is a
standard precaution
-The distal balloon is placed across the fistula or if
this is not possible , then the balloons are
deployed in the ICA at the level of the CCF to
ensure the artery is occluded above and below
the fistula entrance
55. 2-Coils :
-Transarterial packing of the cavernous sinus with
coils is performed after a microcatheter has
been passed through the fistula
-This technique is indicated if the fistula is too
small to permit a balloon to pass into the sinus
-Packing is best performed with highly
thrombogenic coils (e.g. fibre coils or hydrogel-
coated coils)
-The technique involves packing the sinus
adjacent to the fistula as densely as possible
-Though technically easier than using a balloon ,
its main drawback is the risk of incomplete
closure and redirection of the CCF drainage or
recurrence
56. 3-Stent with or without Coils :
-The use of a stent to ‘reinforce’ coils placed within
the sinus is a logical extension of the technical
possibilities , and high-metal-density (low-
porosity) stents are a logical choice
-The stent is deployed in the ICA at the fistula site ,
and coils introduced either transarterially or
transvenously into the sinus
-There have been a few reports of the successful
use of covered stents in the cavernous ICA , but
given the stiffness of current stents , deployment
is technically difficult and the combination of
stent and coil reported more often
57. 4-Liquids Agents :
-N-butyl cyanoacrylate (NBCA) was first used to
treat recurrent CCF when a balloon had deflated
or coils had been inadequate to contain the
fistula
-In this situation , a small quantity of liquid may be
adequate to close the remnant with little risk of
NBCA refluxing into the ICA and to preserve
patency of the ICA
-More recently , reports using Onyx (ev3) , and a
nondetachable balloon placed in the ICA to
protect its lumen during injections , have been
described
-The use of combinations of techniques has
improved the cure rates of endovascular
treatments
58. c) Transvenous Embolisation :
-About 5% of CCFs have more than one
communication between the ICA and the
cavernous sinus which makes transarterial
treatment without stents difficult
-In this situation and when the transarterial route is
considered impossible , the transvenous route is
appropriate
-Access to the cavernous sinus is via the inferior
petrosal sinus , superior ophthalmic vein or even
the pterygoid plexus
59. -Access to the cavernous sinus through the inferior petrosal
sinus is more straightforward than via the SOV
-Direct puncture of the SOV should be avoided in CCF
because it risks causing uncontrollable hemorrhage in
the orbit
-Once in the cavernous sinus the catheter tip should ideally
be positioned adjacent to the fistula but navigating within
the sinus is often difficult
-It may then become necessary to pack the whole sinus
with coils , and care must be taken to avoid partial
closure of the sinus/fistula and redirection of blood flow
to cerebral veins
60. -Redirection of drainage to orbital veins may
exacerbate or cause a rise in venous pressure
within the orbit and threaten vision
-Therefore , embolisation should be planned to
exclude orbital or subarachnoid veins first
-Transvenous packing with coils is slow and
occlusion of the IPS (or other access route)
should be deferred until the operator is confident
that the CCF is closed and that orbital and any
cerebral veins have been disconnected
61. -As for transarterial embolisation , it is performed
with thrombogenic coils (e.g. fibre coils)
-Care should be taken using fibre coils or
hydrogel-coated coils because swelling of the
thrombosed sinus may cause cranial nerve
palsy or pain
-Liquids agents , and in particular Onyx , are an
effective alternative to coils in this situation
62. d) Postoperative Care :
-A minimum period of 48 h bed rest is
recommended with analgesia prescribed
depending on the severity and frequency of
headache
-Pain is a common complaint due to meningeal or
vessel wall stimulation
-Temporary worsening of ophthalmoplegia and
orbital swelling can usually be managed with
medical therapy
63. -The extent of exophthalmos and ophthalmoplegia
should be carefully monitored and auscultation
performed to monitor bruit (which usually
disappears as soon as the fistula is closed)
-If the fistula reopens , the bruit reappears
-A simple technique after balloon placement is to
perform a cranial radiograph in two projections
-This can be used as a baseline against which
future comparison can be made to assess for
any volume changes
64. e) Follow-Up :
-A suggested regime is for a review at 3 months to assess
vision and to ensure continued symptomatic
improvement
-It is doubtful whether delayed follow-up imaging studies
are needed since a CCF that is still occluded 4-5 days
after embolisation is unlikely to recur
-In some centers , catheter angiograms are performed
before the patient leaves hospital , but increasingly , MRI
is used at this stage (i.e. a baseline study) and then
repeated after 3-6 months to confirm satisfactory
resolution of soft tissue swelling , reduction in size of the
SOV and the cavernous sinus